New scientific evidence has strengthened the case for reserving testosterone therapy for well-documented cases of hypogonadism, a condition where the body does not produce enough testosterone, experts concluded in an updated Clinical Practice Guideline.
from Latest Science News -- ScienceDaily http://ift.tt/2FTxJoL
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment